Summary & Overview
HCPCS J3480: Injection, Potassium Chloride, per 2 mEq
HCPCS Level II code J3480 denotes an injection of potassium chloride billed per 2 mEq. This code captures discrete electrolyte replacement therapy commonly used in acute and outpatient settings to treat or prevent hypokalemia. Nationally, accurate coding for potassium chloride injections affects inpatient medication tracking, outpatient infusion billing, and pharmacy reimbursement workflows.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for using J3480, common sites of service, payer coverage patterns, and the operational considerations that influence billing accuracy. The publication highlights benchmarks and typical billing pathways, plus notes on documentation elements essential for claims processing.
The report also outlines policy and payer guidance relevant to injectable electrolyte therapy, potential coding pitfalls, and how J3480 integrates with medication administration service lines. Data not available in the input is noted where applicable; the focus remains on national applicability for clinicians, coders, and revenue cycle professionals seeking concise, actionable information about HCPCS Level II code J3480.
Billing Code Overview
HCPCS Level II code J3480 represents an injection of potassium chloride, billed per 2 mEq. The service is a medication administration involving intravenous or possibly oral/enteral routes depending on clinical context, typically provided in acute care settings such as hospitals, emergency departments, and inpatient units, as well as outpatient infusion centers and clinics when parenteral potassium replacement is required.
Service Type: Medication administration / injectable electrolyte therapy
Typical Site of Service: Hospital inpatient, emergency department, outpatient infusion center, clinic
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult hospitalized for moderate to severe hypokalemia (for example, serum potassium 2.8 mEq/L) associated with diuretic use, gastrointestinal losses, or poor oral intake. The inpatient team (hospitalist, internal medicine or nephrology) orders intravenous potassium replacement. Pharmacy dispenses potassium chloride concentrated solution in vials or premixed bags and nursing administers the medication via peripheral or central IV line per facility protocol, cardiac monitoring, and rate limits. The service reported with J3480 reflects the quantity of potassium chloride dispensed and billed per 2 mEq increment, documented in the medication administration record, physician progress note, and pharmacy charge documentation. Typical sites of service include inpatient hospital ward, intensive care unit, emergency department observation, and inpatient infusion centers when IV replacement is required.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
JW | Drug amount discarded/not administered | When partial vial or bag is discarded and payer requires reporting of wasted medication for specialty drugs (if applicable to contract). |
JZ |